7-(4-(tert-Butyl)benzyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione, 95%, 50mg

tert-Butyl 2-chloro-6,7-dihydrothiazolo[5,4-c]pyridine-5(4H)-carboxylate, 97%, 250mg

Benzyl 5-amino-4-oxopentanoate hydrochloride, 95.0%, 1g

7-fluoro-1H-1,3-benzodiazol-2-amine, 98%, 5g

5-Bromo-4-phenylthiazol-2-amine, 95+%, 1g

Analytical and precision balance PR series Models with internal adjustment, not certified, 0.0001 g, 220 g, PR224 (W)

4-benzyl-1,4-oxazepan-3-one, 1g

9-(3-Bromophenyl)-10-phenylanthracene, 99.0%, 5g

8-Bromo-1-octanol>90.0%(GC)5g

1-(5-(L-PROLINE-1-YL)-PENTYL)-L-PROLINE, 97.0%, 250mg

(4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate, 97.0%, 1g

3,4-Difluoro-5-methylbenzaldehyde, 97.0%, 1g

2-OXO-1-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBOXYLIC ACID, 97.0%, 250mg